Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Dec 1;100(11):2915–2922. doi: 10.1172/JCI119841

Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes.

F Kuipers 1, M C Jong 1, Y Lin 1, M Eck 1, R Havinga 1, V Bloks 1, H J Verkade 1, M H Hofker 1, H Moshage 1, T J Berkel 1, R J Vonk 1, L M Havekes 1
PMCID: PMC508499  PMID: 9389759

Abstract

To explore mechanisms underlying triglyceride (TG) accumulation in livers of chow-fed apo E-deficient mice (Kuipers, F., J.M. van Ree, M.H. Hofker, H. Wolters, G. In't Veld, R.J. Vonk, H.M.G. Princen, and L.M. Havekes. 1996. Hepatology. 24:241-247), we investigated the effects of apo E deficiency on secretion of VLDL-associated TG (a) in vivo in mice, (b) in isolated perfused mouse livers, and (c) in cultured mouse hepatocytes. (a) Hepatic VLDL-TG production rate in vivo, determined after Triton WR1339 injection, was reduced by 46% in apo E-deficient mice compared with controls. To eliminate the possibility that impaired VLDL secretion is caused by aspecific changes in hepatic function due to hypercholesterolemia, VLDL-TG production rates were also measured in apo E-deficient mice after transplantation of wild-type mouse bone marrow. Bone marrow- transplanted apo E-deficient mice, which do not express apo E in hepatocytes, showed normalized plasma cholesterol levels, but VLDL-TG production was reduced by 59%. (b) VLDL-TG production by isolated perfused livers from apo E-deficient mice was 50% lower than production by livers from control mice. Lipid composition of nascent VLDL particles isolated from the perfusate was similar for both groups. (c) Mass VLDL-TG secretion by cultured apo E-deficient hepatocytes was reduced by 23% compared with control values in serum-free medium, and by 61% in the presence of oleate in medium (0. 75 mM) to stimulate lipogenesis. Electron microscopic evaluation revealed a smaller average size for VLDL particles produced by apo E-deficient cells compared with control cells in the presence of oleate (38 and 49 nm, respectively). In short-term labeling studies, apo E-deficient and control cells showed a similar time-dependent accumulation of [3H]TG formed from [3H]glycerol, yet secretion of newly synthesized VLDL-associated [3H]TG by apo E-deficient cells was reduced by 60 and 73% in the absence and presence of oleate, respectively. We conclude that apo E, in addition to its role in lipoprotein clearance, has a physiological function in the VLDL assembly-secretion cascade.

Full Text

The Full Text of this article is available as a PDF (198.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aalto-Setälä K., Fisher E. A., Chen X., Chajek-Shaul T., Hayek T., Zechner R., Walsh A., Ramakrishnan R., Ginsberg H. N., Breslow J. L. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J Clin Invest. 1992 Nov;90(5):1889–1900. doi: 10.1172/JCI116066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boisvert W. A., Spangenberg J., Curtiss L. K. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J Clin Invest. 1995 Aug;96(2):1118–1124. doi: 10.1172/JCI118098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Breslow J. L. Mouse models of atherosclerosis. Science. 1996 May 3;272(5262):685–688. doi: 10.1126/science.272.5262.685. [DOI] [PubMed] [Google Scholar]
  4. Choi S. Y., Komaromy M. C., Chen J., Fong L. G., Cooper A. D. Acceleration of uptake of LDL but not chylomicrons or chylomicron remnants by cells that secrete apoE and hepatic lipase. J Lipid Res. 1994 May;35(5):848–859. [PubMed] [Google Scholar]
  5. Davis R. A., Boogaerts J. R., Borchardt R. A., Malone-McNeal M., Archambault-Schexnayder J. Intrahepatic assembly of very low density lipoproteins. Varied synthetic response of individual apolipoproteins to fasting. J Biol Chem. 1985 Nov 15;260(26):14137–14144. [PubMed] [Google Scholar]
  6. Davis R. A., McNeal M. M., Moses R. L. Intrahepatic assembly of very low density lipoprotein. Competition by cholesterol esters for the hydrophobic core. J Biol Chem. 1982 Mar 10;257(5):2634–2640. [PubMed] [Google Scholar]
  7. Elovson J., Chatterton J. E., Bell G. T., Schumaker V. N., Reuben M. A., Puppione D. L., Reeve J. R., Jr, Young N. L. Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. J Lipid Res. 1988 Nov;29(11):1461–1473. [PubMed] [Google Scholar]
  8. Fazio S., Yao Z., McCarthy B. J., Rall S. C., Jr Synthesis and secretion of apolipoprotein E occur independently of synthesis and secretion of apolipoprotein B-containing lipoproteins in HepG2 cells. J Biol Chem. 1992 Apr 5;267(10):6941–6945. [PubMed] [Google Scholar]
  9. Fazio S., Yao Z. The enhanced association of apolipoprotein E with apolipoprotein B-containing lipoproteins in serum-stimulated hepatocytes occurs intracellularly. Arterioscler Thromb Vasc Biol. 1995 May;15(5):593–600. doi: 10.1161/01.atv.15.5.593. [DOI] [PubMed] [Google Scholar]
  10. Gamble W., Vaughan M., Kruth H. S., Avigan J. Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J Lipid Res. 1978 Nov;19(8):1068–1070. [PubMed] [Google Scholar]
  11. Gibbons G. F. Assembly and secretion of hepatic very-low-density lipoprotein. Biochem J. 1990 May 15;268(1):1–13. doi: 10.1042/bj2680001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ginsberg H. N. Synthesis and secretion of apolipoprotein B from cultured liver cells. Curr Opin Lipidol. 1995 Oct;6(5):275–280. doi: 10.1097/00041433-199510000-00006. [DOI] [PubMed] [Google Scholar]
  13. Gordon D. A., Jamil H., Sharp D., Mullaney D., Yao Z., Gregg R. E., Wetterau J. Secretion of apolipoprotein B-containing lipoproteins from HeLa cells is dependent on expression of the microsomal triglyceride transfer protein and is regulated by lipid availability. Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7628–7632. doi: 10.1073/pnas.91.16.7628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Greeve J., Altkemper I., Dieterich J. H., Greten H., Windler E. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J Lipid Res. 1993 Aug;34(8):1367–1383. [PubMed] [Google Scholar]
  15. Gretch D. G., Sturley S. L., Attie A. D. Human apolipoprotein E mediates processive buoyant lipoprotein formation in insect larvae. Biochemistry. 1995 Jan 17;34(2):545–552. doi: 10.1021/bi00002a020. [DOI] [PubMed] [Google Scholar]
  16. Hahn S. E., Goldberg D. M. Factors affecting the regulation of apo B secretion by liver cells. J Clin Lab Anal. 1995;9(6):431–449. doi: 10.1002/jcla.1860090616. [DOI] [PubMed] [Google Scholar]
  17. Hamilton R. L., Wong J. S., Guo L. S., Krisans S., Havel R. J. Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections. J Lipid Res. 1990 Sep;31(9):1589–1603. [PubMed] [Google Scholar]
  18. Ji Z. S., Fazio S., Lee Y. L., Mahley R. W. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J Biol Chem. 1994 Jan 28;269(4):2764–2772. [PubMed] [Google Scholar]
  19. Jong M. C., Dahlmans V. E., van Gorp P. J., Breuer M. L., Mol M. J., van der Zee A., Frants R. R., Hofker M. H., Havekes L. M. Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1. Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):934–940. doi: 10.1161/01.atv.16.8.934. [DOI] [PubMed] [Google Scholar]
  20. Khan B., Wilcox H. G., Heimberg M. Cholesterol is required for secretion of very-low-density lipoprotein by rat liver. Biochem J. 1989 Mar 15;258(3):807–816. doi: 10.1042/bj2580807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Klaunig J. E., Goldblatt P. J., Hinton D. E., Lipsky M. M., Chacko J., Trump B. F. Mouse liver cell culture. I. Hepatocyte isolation. In Vitro. 1981 Oct;17(10):913–925. doi: 10.1007/BF02618288. [DOI] [PubMed] [Google Scholar]
  22. Kuipers F., van Ree J. M., Hofker M. H., Wolters H., In't Veld G., Havinga R., Vonk R. J., Princen H. M., Havekes L. M. Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver. Hepatology. 1996 Jul;24(1):241–247. doi: 10.1002/hep.510240138. [DOI] [PubMed] [Google Scholar]
  23. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  24. Lin Y., Havinga R., Verkade H. J., Moshage H., Slooff M. J., Vonk R. J., Kuipers F. Bile acids suppress the secretion of very-low-density lipoprotein by human hepatocytes in primary culture. Hepatology. 1996 Feb;23(2):218–228. doi: 10.1002/hep.510230204. [DOI] [PubMed] [Google Scholar]
  25. Lin Y., Smit M. J., Havinga R., Verkade H. J., Vonk R. J., Kuipers F. Differential effects of eicosapentaenoic acid on glycerolipid and apolipoprotein B metabolism in primary human hepatocytes compared to HepG2 cells and primary rat hepatocytes. Biochim Biophys Acta. 1995 Apr 28;1256(1):88–96. doi: 10.1016/0005-2760(95)00006-x. [DOI] [PubMed] [Google Scholar]
  26. Linton M. F., Atkinson J. B., Fazio S. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 1995 Feb 17;267(5200):1034–1037. doi: 10.1126/science.7863332. [DOI] [PubMed] [Google Scholar]
  27. Lombardi P., Mulder M., van der Boom H., Frants R. R., Havekes L. M. Inefficient degradation of triglyceride-rich lipoprotein by HepG2 cells is due to a retarded transport to the lysosomal compartment. J Biol Chem. 1993 Dec 15;268(35):26113–26119. [PubMed] [Google Scholar]
  28. Mahley R. W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988 Apr 29;240(4852):622–630. doi: 10.1126/science.3283935. [DOI] [PubMed] [Google Scholar]
  29. Nishina P. M., Verstuyft J., Paigen B. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J Lipid Res. 1990 May;31(5):859–869. [PubMed] [Google Scholar]
  30. Plump A. S., Breslow J. L. Apolipoprotein E and the apolipoprotein E-deficient mouse. Annu Rev Nutr. 1995;15:495–518. doi: 10.1146/annurev.nu.15.070195.002431. [DOI] [PubMed] [Google Scholar]
  31. Plump A. S., Smith J. D., Hayek T., Aalto-Setälä K., Walsh A., Verstuyft J. G., Rubin E. M., Breslow J. L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992 Oct 16;71(2):343–353. doi: 10.1016/0092-8674(92)90362-g. [DOI] [PubMed] [Google Scholar]
  32. Princen H. M., Huijsmans C. M., Kuipers F., Vonk R. J., Kempen H. J. Ketoconazole blocks bile acid synthesis in hepatocyte monolayer cultures and in vivo in rat by inhibiting cholesterol 7 alpha-hydroxylase. J Clin Invest. 1986 Oct;78(4):1064–1071. doi: 10.1172/JCI112662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rensen P. C., van Berkel T. J. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. J Biol Chem. 1996 Jun 21;271(25):14791–14799. doi: 10.1074/jbc.271.25.14791. [DOI] [PubMed] [Google Scholar]
  34. Schippers I. J., Moshage H., Roelofsen H., Müller M., Heymans H. S., Ruiters M., Kuipers F. Immortalized human hepatocytes as a tool for the study of hepatocytic (de-)differentiation. Cell Biol Toxicol. 1997 Jul;13(4-5):375–386. doi: 10.1023/a:1007404028681. [DOI] [PubMed] [Google Scholar]
  35. Schwiegelshohn B., Presley J. F., Gorecki M., Vogel T., Carpentier Y. A., Maxfield F. R., Deckelbaum R. J. Effects of apoprotein E on intracellular metabolism of model triglyceride-rich particles are distinct from effects on cell particle uptake. J Biol Chem. 1995 Jan 27;270(4):1761–1769. doi: 10.1074/jbc.270.4.1761. [DOI] [PubMed] [Google Scholar]
  36. Sharp D., Blinderman L., Combs K. A., Kienzle B., Ricci B., Wager-Smith K., Gil C. M., Turck C. W., Bouma M. E., Rader D. J. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature. 1993 Sep 2;365(6441):65–69. doi: 10.1038/365065a0. [DOI] [PubMed] [Google Scholar]
  37. Shoulders C. C., Brett D. J., Bayliss J. D., Narcisi T. M., Jarmuz A., Grantham T. T., Leoni P. R., Bhattacharya S., Pease R. J., Cullen P. M. Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein. Hum Mol Genet. 1993 Dec;2(12):2109–2116. doi: 10.1093/hmg/2.12.2109. [DOI] [PubMed] [Google Scholar]
  38. Smit M. J., Beekhuis H., Duursma A. M., Bouma J. M., Gruber M. Catabolism of circulating enzymes: plasma clearance, endocytosis, and breakdown of lactate dehydrogenase-1 in rabbits. Clin Chem. 1988 Dec;34(12):2475–2480. [PubMed] [Google Scholar]
  39. Strobl W., Gorder N. L., Fienup G. A., Lin-Lee Y. C., Gotto A. M., Jr, Patsch W. Effect of sucrose diet on apolipoprotein biosynthesis in rat liver. Increase in apolipoprotein E gene transcription. J Biol Chem. 1989 Jan 15;264(2):1190–1194. [PubMed] [Google Scholar]
  40. Vance D. E., Weinstein D. B., Steinberg D. Isolation and analysis of lipoproteins secreted by rat liver hepatocytes. Biochim Biophys Acta. 1984 Jan 17;792(1):39–47. doi: 10.1016/0005-2760(84)90280-7. [DOI] [PubMed] [Google Scholar]
  41. Wu X., Shang A., Jiang H., Ginsberg H. N. Low rates of apoB secretion from HepG2 cells result from reduced delivery of newly synthesized triglyceride to a "secretion-coupled" pool. J Lipid Res. 1996 Jun;37(6):1198–1206. [PubMed] [Google Scholar]
  42. Yao Z., McLeod R. S. Synthesis and secretion of hepatic apolipoprotein B-containing lipoproteins. Biochim Biophys Acta. 1994 May 13;1212(2):152–166. doi: 10.1016/0005-2760(94)90249-6. [DOI] [PubMed] [Google Scholar]
  43. Zhang S. H., Reddick R. L., Piedrahita J. A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992 Oct 16;258(5081):468–471. doi: 10.1126/science.1411543. [DOI] [PubMed] [Google Scholar]
  44. van Ree J. H., van den Broek W. J., Dahlmans V. E., Groot P. H., Vidgeon-Hart M., Frants R. R., Wieringa B., Havekes L. M., Hofker M. H. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. Atherosclerosis. 1994 Nov;111(1):25–37. doi: 10.1016/0021-9150(94)90188-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES